Preview

Antibiot Khimioter = Antibiotics and Chemotherapy

Advanced search

OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE β-LACTAMASE INHIBITOR, ANTIBIOTIC AND β-LACTAM 'ENHANCER'

About the Authors

A. .. Morinaka
Meiji Seika Pharma Co., Ltd
Russian Federation


Y. .. Tsutsumi

Russian Federation


M. .. Yamada

Russian Federation


K. .. Suzuki

Russian Federation


T. .. Watanabe

Russian Federation


T. .. Abe

Russian Federation


T. .. Furuuchi

Russian Federation


S. .. Inamura

Russian Federation


Y. .. Sakamaki

Russian Federation


N. .. Mitsuhashi

Russian Federation


T. .. Ida

Russian Federation


D. M. Livermore

Russian Federation


Review

For citations:


Morinaka A..., Tsutsumi Y..., Yamada M..., Suzuki K..., Watanabe T..., Abe T..., Furuuchi T..., Inamura S..., Sakamaki Y..., Mitsuhashi N..., Ida T..., Livermore D.M. OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE β-LACTAMASE INHIBITOR, ANTIBIOTIC AND β-LACTAM 'ENHANCER'. Antibiot Khimioter = Antibiotics and Chemotherapy. 2015;60(11-12):51-52. (In Russ.)

Views: 298


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0235-2990 (Print)